Wang, X., Hu, C. S., Petersen, B., Qiu, J., Ye, F., Houldsworth, J., . . . Hoffman, R. (2018). Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells. Blood Adv.
Chicago-tyylinen lähdeviittausWang, Xiaoli, Cing Siang Hu, Bruce Petersen, Jiajing Qiu, Fei Ye, Jane Houldsworth, Kevin Eng, Fei Huang, ja Ronald Hoffman. "Imetelstat, a Telomerase Inhibitor, Is Capable of Depleting Myelofibrosis Stem and Progenitor Cells." Blood Adv 2018.
MLA-viiteWang, Xiaoli, et al. "Imetelstat, a Telomerase Inhibitor, Is Capable of Depleting Myelofibrosis Stem and Progenitor Cells." Blood Adv 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.